Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial
Article in BMC Cancer (September 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in BMC Cancer (September 2023)
Article in Scientific Reports (May 2022)
Article in Journal of Molecular Endocrinology (August 2020)